These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 7302893
1. The thrombolytic activity of streptokinase in the rabbit. English PD, Smith RA, Dupe RJ, Green J, Hibbs MJ. Thromb Haemost; 1981 Aug 28; 46(2):535-7. PubMed ID: 7302893 [Abstract] [Full Text] [Related]
2. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis. Dupe RJ, English PD, Smith RA, Green J. Thromb Haemost; 1981 Aug 28; 46(2):528-34. PubMed ID: 6458112 [Abstract] [Full Text] [Related]
4. Fibrinogen degradation products in plasma following induced hyperfibrinolysis. Chek JB, Panchenko NI. East Afr Med J; 2000 Apr 28; 77(4):217-20. PubMed ID: 12858907 [Abstract] [Full Text] [Related]
5. [The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation]. Bashkov GV, Aĭsina RB, Kazanskaia NF, Makarov VA, Sirotenko AV, Popova GIu, Zhitkova IuV. Farmakol Toksikol; 1991 Apr 28; 54(2):46-50. PubMed ID: 1884796 [Abstract] [Full Text] [Related]
6. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK). Lipinski B, Gurewich V, Hyde E. Thromb Diath Haemorrh; 1975 Sep 30; 34(1):351. PubMed ID: 1188799 [No Abstract] [Full Text] [Related]
8. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator. Berridge DC, Earnshaw JJ, Westby JC, Makin GS, Hopkinson BR. Thromb Haemost; 1989 Apr 25; 61(2):275-8. PubMed ID: 2501898 [Abstract] [Full Text] [Related]
9. [Streptokinase and Staphylokinase: Differences in the Kinetics and Mechanism of Their Interaction with Plasminogen, Inhibitors and Fibrin]. Aisina RB, Mukhametova LI, Gulin DA, Gershkovich KB, Varfolomeyev SD. Bioorg Khim; 2015 Apr 25; 41(5):565-78. PubMed ID: 26762094 [Abstract] [Full Text] [Related]
10. Intermittent plasminogen-streptokinase treatment of deep vein thrombosis. Scully MF, Lane DA, Sagar S, Thomas DP, Kakkar VV. Thromb Haemost; 1977 Feb 28; 37(1):162-9. PubMed ID: 138963 [Abstract] [Full Text] [Related]
12. Limiting systemic plasminogenolysis reduces the bleeding potential for tissue-type plasminogen activators but not for streptokinase. Thomas GR, Thibodeaux H, Errett CJ, Badillo JM, Wu DT, Refino CJ, Keyt BA, Bennett WF. Thromb Haemost; 1996 Jun 28; 75(6):915-20. PubMed ID: 8822586 [Abstract] [Full Text] [Related]
13. [Index of fibrinolysis with new fibrin plate (author's transl)]. Hishikawa Y, Sugie I. Nihon Seirigaku Zasshi; 1977 Jun 28; 39(1):1-11. PubMed ID: 140239 [Abstract] [Full Text] [Related]
14. [The fibrinolytic system and its activators]. Seifried E. Z Gesamte Inn Med; 1993 Jun 28; 48(6-7):272-82. PubMed ID: 8333223 [Abstract] [Full Text] [Related]
15. In vitro effects of the acylated streptokinase-plasminogen activator complex BRL 33 575 incubated with normal human plasma. Lämmle B, Noll G, Tran TH, Lohri A, Duckert F. Thromb Haemost; 1984 Jul 29; 51(3):403-5. PubMed ID: 6548585 [Abstract] [Full Text] [Related]
17. Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis. Electricwala A, Emeis JJ, Atkinson T. J Pharmacol Exp Ther; 1986 Jul 29; 238(1):254-8. PubMed ID: 2425075 [Abstract] [Full Text] [Related]
19. The susceptibility of plasma to activation of fibrinolysis. Stief TW. Blood Coagul Fibrinolysis; 1993 Feb 29; 4(1):123-5. PubMed ID: 8457639 [Abstract] [Full Text] [Related]